Spectrum Pharmaceuticals Appoints New President and COO - - BioPharm International

ADVERTISEMENT

Spectrum Pharmaceuticals Appoints New President and COO



Spectrum Pharmaceuticals, a biotechnology company with a primary focus in hematology and oncology, has appointed Joseph Turgeon, previously senior vice president and COO, as president and COO, replacing Ken Keller. Thomas Riga, previously vice president, corporate accounts, will become the senior vice president, COO.

Turgeon joined Spectrum in October 2012 and has over 30 years of pharmaceutical sales experience. Prior to joining the Spectrum, hespent 22 years at Amgen as VP of sales. Riga has over 15 years of pharmaceutical sales and management experience and has worked at Amgen, EliLilly, and Dendreon.

Source: Spectrum Pharmaceuticals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pandemic Vaccine Facility Dedicated in Texas
September 19, 2014
GSK Fined in China Bribery Scandal
September 19, 2014
Guideline Delineates How to Implement GS1 Standards to Support DSCSA
September 19, 2014
GPhA Supports Restricted Access Bill
September 18, 2014
Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
Author Guidelines

Click here